Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2026-01-15 @ 4:05 AM
Study NCT ID:
NCT02348359
Status:
TERMINATED
Last Update Posted:
2022-02-11
First Post:
2015-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
X-82 to Treat Age-related Macular Degeneration
Sponsor:
Tyrogenex
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
X82-OPH-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None